表紙
市場調查報告書

全球心臟生物標記市場

Cardiac Biomarkers

出版商 Global Industry Analysts, Inc. 商品編碼 925936
出版日期 內容資訊 英文 177 Pages
商品交期: 最快1-2個工作天內
價格
全球心臟生物標記市場 Cardiac Biomarkers
出版日期: 2020年07月01日內容資訊: 英文 177 Pages
簡介

本報告提供全球心臟生物標記市場概要,提供主要企業,市場趨勢·促進因素,全球市場預測,各地區市場分析,競爭情形等相關的系統性資訊。

第1章 簡介·調查手法·調查範圍

第2章 摘要整理

  • 市場概要
  • 焦點企業
    • Abbott Diagnostics, Inc. (美國)
    • Quidel Corporation (美國)
    • Beckman Coulter, Inc. (美國)
    • BG Medicine, Inc. (美國)
    • biomerieux SA (法國)
    • Boditech Med Inc. (韓國)
    • Labsystems Diagnostics OY (芬蘭)
    • LifeSign LLC (美國)
    • LSI Medience Corporation (日本)
    • Ortho-Clinical Diagnostics, Inc. (美國)
    • Randox Laboratories Ltd. (英國)
    • Response Biomedical Corp. (加拿大)
    • Roche Diagnostics (瑞士)
    • Siemens Healthineers (美國)
    • Merck KGaA (德國)
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他的亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • UAE
  • 其他中東
  • 非洲

第4章 競爭

目錄
Product Code: MCP-1632

Global Cardiac Biomarkers Market to Reach $10.8 Billion by 2027

Amid the COVID-19 crisis, the global market for Cardiac Biomarkers estimated at US$6.2 Billion in the year 2020, is projected to reach a revised size of US$10.8 Billion by 2027, growing at aCAGR of 8.1% over the period 2020-2027. Laboratory Testing, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$6.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Point-of-Care Testing segment is readjusted to a revised 8.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.7 Billion, While China is Forecast to Grow at 12.2% CAGR

The Cardiac Biomarkers market in the U.S. is estimated at US$1.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.4 Billion by the year 2027 trailing a CAGR of 12.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.We bring years of research experience to this 16th edition of our report. The 177-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Diagnostics
  • Beckman Coulter Inc.
  • BG Medicine
  • bioMerieux SA
  • Boditech Med Inc.
  • Labsystems Diagnostics OY
  • LifeSign LLC
  • LSI Medience Corp.
  • Merck KGaA
  • Ortho-Clinical Diagnostics Inc.
  • Quidel Corporation
  • Randox Laboratories
  • Response Biomedical Corp.
  • Roche Diagnostics Corp.
  • Siemens Healthineers

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • A Curtain Raiser
  • Major Cardiac Markers and their Properties
  • Recent Market Activity
  • Market Set to Record Strong Growth Led by Advancements in Cardiac Biomarker Combinations
  • North America Corners Biggest Slice, Asia-Pacific to Dictate Market Momentum
  • Laboratory Testing Remains Gold Standard, POC Testing Rapidly Gains Traction
  • Analysis by Type of Cardiac Biomarker Assay/Test
  • Competitive Landscape
  • Intense Competition among Players in the Cardiac Diagnostics Market
  • Leading Vendors Focus on Curtailing Turnaround Time of POC Cardiac Testing Kits
  • Cardiac Markers Point-Of-Care Testing (POC) Cardiac Testing Segment: Major Players and their Operating Brands
  • Other Recent Innovations
  • Lipid Biomarker Panel to Detect HfrEF
  • VectraplexECG System with CEB(r) Cardiac Electrical Biomarker
  • Cardiac Biomarkers on Smartphone
  • Stringent Regulations and Other Challenges
  • Global Competitor Market Shares
  • Cardiac Biomarkers Competitor Market Share Scenario Worldwide (in %): 2020 & 2029
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

  • Abbott Diagnostics, Inc. (USA)
  • Quidel Corporation (USA)
  • Beckman Coulter, Inc. (USA)
  • BG Medicine, Inc. (USA)
  • biomerieux SA (France)
  • Boditech Med Inc. (South Korea)
  • Labsystems Diagnostics OY (Finland)
  • LifeSign LLC (USA)
  • LSI Medience Corporation (Japan)
  • Ortho-Clinical Diagnostics, Inc. (USA)
  • Randox Laboratories Ltd. (UK)
  • Response Biomedical Corp. (Canada)
  • Roche Diagnostics (Switzerland)
  • Siemens Healthineers (USA)
  • Merck KGaA (Germany)

3. MARKET TRENDS & DRIVERS

  • The Grim Reality of Mounting Economic and Social Burden of Cardiovascular Disease
  • Population Explosion, Ballooning Geriatric Populace, Longer Life Expectancy Contributing to Rising Tide of CVDs
  • Cardiac Biomarkers Hold the Key to Timely, Accurate Diagnosis & Prognosis
  • Commercialization of Novel Biomarkers to Drive Market Growth
  • Personalized Medicine, Companion Diagnostics Open Up Opportunities for Cardiac Biomarker Developers
  • Cardiac Biomarkers - A Powerful Tool for Patient Triaging
  • Cardiac Biomarkers Market Transitions from Mono-Marker to Multi-Marker Assays
  • Government Support Instrumental for Boosting Market Momentum
  • Secretoneurin Biomarker - a Potential Game Changer for Diagnosis of Cardiac Arrhythmias
  • High-Performance Techniques Drive Biomarker Discovery in Cardiology
  • Biomarkers for Acute Coronary Syndromes (ACS): A Leading Segment
  • Biomarkers - A Promising Diagnostic Tool for ACS
  • Biomarker Discovery for ACS to Undergo Significant Changes
  • Cardiac Biomarker Play Critical Role in Stroke Diagnosis
  • Cardiac Biomarkers to Find a Place in Neonatal Diagnosis and Treatment
  • Specificity, Sensitivity, Side Effects, Cost Concerns Hinder Market Growth

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Cardiac Biomarkers Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 2: Cardiac Biomarkers Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019
  • TABLE 3: Cardiac Biomarkers Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Laboratory Testing (Location Type) World Market by Region/Country in US$ Thousand: 2020 to 2027
  • TABLE 5: Laboratory Testing (Location Type) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019
  • TABLE 6: Laboratory Testing (Location Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Point-of-Care Testing (Location Type) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
  • TABLE 8: Point-of-Care Testing (Location Type) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019
  • TABLE 9: Point-of-Care Testing (Location Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Cardiac Biomarkers Market Share (in %) by Company: 2020 & 2025
    • Market Analytics
    • TABLE 10: United States Cardiac Biomarkers Market Estimates and Projections in US$ Thousand by Location Type: 2020 to 2027
    • TABLE 11: Cardiac Biomarkers Market in the United States by Location Type: A Historic Review in US$ Thousand for 2012-2019
    • TABLE 12: United States Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 13: Canadian Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2020 to 2027
    • TABLE 14: Canadian Cardiac Biomarkers Historic Market Review by Location Type in US$ Thousand: 2012-2019
    • TABLE 15: Cardiac Biomarkers Market in Canada: Percentage Share Breakdown of Sales by Location Type for 2012, 2020, and 2027
  • JAPAN
    • TABLE 16: Japanese Market for Cardiac Biomarkers: Annual Sales Estimates and Projections in US$ Thousand by Location Type for the Period 2020-2027
    • TABLE 17: Cardiac Biomarkers Market in Japan: Historic Sales Analysis in US$ Thousand by Location Type for the Period 2012-2019
    • TABLE 18: Japanese Cardiac Biomarkers Market Share Analysis by Location Type: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 19: Chinese Cardiac Biomarkers Market Growth Prospects in US$ Thousand by Location Type for the Period 2020-2027
    • TABLE 20: Cardiac Biomarkers Historic Market Analysis in China in US$ Thousand by Location Type: 2012-2019
    • TABLE 21: Chinese Cardiac Biomarkers Market by Location Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • EUROPE
    • Market Facts & Figures
    • European Cardiac Biomarkers Market: Competitor Market Share Scenario (in %) for 2020 & 2025
    • Market Analytics
    • TABLE 22: European Cardiac Biomarkers Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027
    • TABLE 23: Cardiac Biomarkers Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019
    • TABLE 24: European Cardiac Biomarkers Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 25: European Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2020-2027
    • TABLE 26: Cardiac Biomarkers Market in Europe in US$ Thousand by Location Type: A Historic Review for the Period 2012-2019
    • TABLE 27: European Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 28: Cardiac Biomarkers Market in France by Location Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
    • TABLE 29: French Cardiac Biomarkers Historic Market Scenario in US$ Thousand by Location Type: 2012-2019
    • TABLE 30: French Cardiac Biomarkers Market Share Analysis by Location Type: 2012 VS 2020 VS 2027
  • GERMANY
    • TABLE 31: Cardiac Biomarkers Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2020-2027
    • TABLE 32: German Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2012-2019
    • TABLE 33: German Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 34: Italian Cardiac Biomarkers Market Growth Prospects in US$ Thousand by Location Type for the Period 2020-2027
    • TABLE 35: Cardiac Biomarkers Historic Market Analysis in Italy in US$ Thousand by Location Type: 2012-2019
    • TABLE 36: Italian Cardiac Biomarkers Market by Location Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • UNITED KINGDOM
    • TABLE 37: United Kingdom Market for Cardiac Biomarkers: Annual Sales Estimates and Projections in US$ Thousand by Location Type for the Period 2020-2027
    • TABLE 38: Cardiac Biomarkers Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Location Type for the Period 2012-2019
    • TABLE 39: United Kingdom Cardiac Biomarkers Market Share Analysis by Location Type: 2012 VS 2020 VS 2027
  • SPAIN
    • TABLE 40: Spanish Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2020 to 2027
    • TABLE 41: Spanish Cardiac Biomarkers Historic Market Review by Location Type in US$ Thousand: 2012-2019
    • TABLE 42: Cardiac Biomarkers Market in Spain: Percentage Share Breakdown of Sales by Location Type for 2012, 2020, and 2027
  • RUSSIA
    • TABLE 43: Russian Cardiac Biomarkers Market Estimates and Projections in US$ Thousand by Location Type: 2020 to 2027
    • TABLE 44: Cardiac Biomarkers Market in Russia by Location Type: A Historic Review in US$ Thousand for 2012-2019
    • TABLE 45: Russian Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 46: Rest of Europe Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2020-2027
    • TABLE 47: Cardiac Biomarkers Market in Rest of Europe in US$ Thousand by Location Type: A Historic Review for the Period 2012-2019
    • TABLE 48: Rest of Europe Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 49: Asia-Pacific Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
    • TABLE 50: Cardiac Biomarkers Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2012-2019
    • TABLE 51: Asia-Pacific Cardiac Biomarkers Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 52: Cardiac Biomarkers Market in Asia-Pacific by Location Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
    • TABLE 53: Asia-Pacific Cardiac Biomarkers Historic Market Scenario in US$ Thousand by Location Type: 2012-2019
    • TABLE 54: Asia-Pacific Cardiac Biomarkers Market Share Analysis by Location Type: 2012 VS 2020 VS 2027
  • AUSTRALIA
    • TABLE 55: Cardiac Biomarkers Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2020-2027
    • TABLE 56: Australian Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2012-2019
    • TABLE 57: Australian Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
  • INDIA
    • TABLE 58: Indian Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2020 to 2027
    • TABLE 59: Indian Cardiac Biomarkers Historic Market Review by Location Type in US$ Thousand: 2012-2019
    • TABLE 60: Cardiac Biomarkers Market in India: Percentage Share Breakdown of Sales by Location Type for 2012, 2020, and 2027
  • SOUTH KOREA
    • TABLE 61: Cardiac Biomarkers Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2020-2027
    • TABLE 62: South Korean Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2012-2019
    • TABLE 63: Cardiac Biomarkers Market Share Distribution in South Korea by Location Type: 2012 VS 2020 VS 2027
  • REST OF ASIA-PACIFIC
    • TABLE 64: Rest of Asia-Pacific Market for Cardiac Biomarkers: Annual Sales Estimates and Projections in US$ Thousand by Location Type for the Period 2020-2027
    • TABLE 65: Cardiac Biomarkers Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Location Type for the Period 2012-2019
    • TABLE 66: Rest of Asia-Pacific Cardiac Biomarkers Market Share Analysis by Location Type: 2012 VS 2020 VS 2027
  • LATIN AMERICA
    • TABLE 67: Latin American Cardiac Biomarkers Market Trends by Region/Country in US$ Thousand: 2020-2027
    • TABLE 68: Cardiac Biomarkers Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2012-2019
    • TABLE 69: Latin American Cardiac Biomarkers Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
    • TABLE 70: Latin American Cardiac Biomarkers Market Growth Prospects in US$ Thousand by Location Type for the Period 2020-2027
    • TABLE 71: Cardiac Biomarkers Historic Market Analysis in Latin America in US$ Thousand by Location Type: 2012-2019
    • TABLE 72: Latin American Cardiac Biomarkers Market by Location Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • ARGENTINA
    • TABLE 73: Argentinean Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2020-2027
    • TABLE 74: Cardiac Biomarkers Market in Argentina in US$ Thousand by Location Type: A Historic Review for the Period 2012-2019
    • TABLE 75: Argentinean Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
  • BRAZIL
    • TABLE 76: Cardiac Biomarkers Market in Brazil by Location Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
    • TABLE 77: Brazilian Cardiac Biomarkers Historic Market Scenario in US$ Thousand by Location Type: 2012-2019
    • TABLE 78: Brazilian Cardiac Biomarkers Market Share Analysis by Location Type: 2012 VS 2020 VS 2027
  • MEXICO
    • TABLE 79: Cardiac Biomarkers Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2020-2027
    • TABLE 80: Mexican Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2012-2019
    • TABLE 81: Mexican Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
  • REST OF LATIN AMERICA
    • TABLE 82: Rest of Latin America Cardiac Biomarkers Market Estimates and Projections in US$ Thousand by Location Type: 2020 to 2027
    • TABLE 83: Cardiac Biomarkers Market in Rest of Latin America by Location Type: A Historic Review in US$ Thousand for 2012-2019
    • TABLE 84: Rest of Latin America Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
  • MIDDLE EAST
    • TABLE 85: The Middle East Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
    • TABLE 86: Cardiac Biomarkers Market in the Middle East by Region/Country in US$ Thousand: 2012-2019
    • TABLE 87: The Middle East Cardiac Biomarkers Market Share Breakdown by Region/Country: 2012, 2020, and 2027
    • TABLE 88: The Middle East Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2020 to 2027
    • TABLE 89: The Middle East Cardiac Biomarkers Historic Market by Location Type in US$ Thousand: 2012-2019
    • TABLE 90: Cardiac Biomarkers Market in the Middle East: Percentage Share Breakdown of Sales by Location Type for 2012,2020, and 2027
  • IRAN
    • TABLE 91: Iranian Market for Cardiac Biomarkers: Annual Sales Estimates and Projections in US$ Thousand by Location Type for the Period 2020-2027
    • TABLE 92: Cardiac Biomarkers Market in Iran: Historic Sales Analysis in US$ Thousand by Location Type for the Period 2012-2019
    • TABLE 93: Iranian Cardiac Biomarkers Market Share Analysis by Location Type: 2012 VS 2020 VS 2027
  • ISRAEL
    • TABLE 94: Israeli Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2020-2027
    • TABLE 95: Cardiac Biomarkers Market in Israel in US$ Thousand by Location Type: A Historic Review for the Period 2012-2019
    • TABLE 96: Israeli Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
  • SAUDI ARABIA
    • TABLE 97: Saudi Arabian Cardiac Biomarkers Market Growth Prospects in US$ Thousand by Location Type for the Period 2020-2027
    • TABLE 98: Cardiac Biomarkers Historic Market Analysis in Saudi Arabia in US$ Thousand by Location Type: 2012-2019
    • TABLE 99: Saudi Arabian Cardiac Biomarkers Market by Location Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • UNITED ARAB EMIRATES
    • TABLE 100: Cardiac Biomarkers Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2020-2027
    • TABLE 101: United Arab Emirates Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2012-2019
    • TABLE 102: Cardiac Biomarkers Market Share Distribution in United Arab Emirates by Location Type: 2012 VS 2020 VS 2027
  • REST OF MIDDLE EAST
    • TABLE 103: Cardiac Biomarkers Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2020-2027
    • TABLE 104: Rest of Middle East Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2012-2019
    • TABLE 105: Rest of Middle East Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
  • AFRICA
    • TABLE 106: African Cardiac Biomarkers Market Estimates and Projections in US$ Thousand by Location Type: 2020 to 2027
    • TABLE 107: Cardiac Biomarkers Market in Africa by Location Type: A Historic Review in US$ Thousand for 2012-2019
    • TABLE 108: African Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 39